ArticleThe oncologist2026

Anti-EGFR plus anti-PD1 in advanced and refractory cutaneous squamous cell carcinoma: a cohort study.

Camille Guy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.